“Femarelle … inhibits menopausal symptoms without thrombogenicity…”

The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women


Pretreatment study of all seven women with shortened closure times confirmed
abnormalities associated with thrombophilia: four women were heterozygous for the factor
V Leiden gene mutation, one was heterozygous for the prothrombin gene mutation, one was
found to have protein S deficiency, and one had increased anticardiolipin antibodies. All
participants reported improved symptoms during the treatment period. No significant
change in closure times was found in the normally clotting participants after 3 or 8 weeks
of Femarelle therapy (P > 0.26). No significant change in closure time was seen in the seven
thrombophilic women after 3 or 8 weeks or 1 year of Femarelle treatment (P > 0.26). The
regression curve for measures over time was not significant (P = 0.26).

Contact Us


TruLife Distribution
401 E. Las Olas Blvd Suite 1400
Fort Lauderdale, Florida

* The products and the claims made about specific products on or through the Website have not been evaluated by the United States Food and Drug Administration (not required) and are not intended to diagnose, treat, cure or prevent disease. The information provided on this Site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this Website for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional, and carefully read all information provided on or in any product label or packaging, before using any medication or nutritional, herbal or homeopathic product (including regarding any interactions between any medication you are currently taking and such products), before starting any treatment for a health problem, or if you have or suspect you might have a health problem. Unless advised by your healthcare professional, biological age should not be used to determine or alter any age-related health or medical treatments based on your chronological age.